Summit Therapeutics (SMMT) Amortizatization of Intangibles (2019 - 2026)

Summit Therapeutics has reported Amortizatization of Intangibles for 8 years, with the latest figure at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 42.18% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.3 million (up 60.64% YoY), and the FY2025 full-year result was $7.0 million, up 171.97% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $4.2 million, up from $3.0 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $4.2 million in Q1 2026, with the low at -$2.4 million in Q4 2024.
• Historically, Amortizatization of Intangibles has averaged $1.1 million across 5 years, with a median of $402000.0 in 2024.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles tumbled 1229.81% — and 2025, when it surged 637.81%.
• Summit Therapeutics' Amortizatization of Intangibles stood at -$960000.0 in 2022, then jumped by 121.67% to $208000.0 in 2023, then plunged by 1229.81% to -$2.4 million in 2024, then jumped by 228.38% to $3.0 million in 2025, then soared by 39.77% to $4.2 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $4.2 million (Q1 2026), $3.0 million (Q4 2025), and $1.0 million (Q2 2025), per Business Quant data.